Cargando…
The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995–2005
BACKGROUND: The use of genotyping to distinguish recrudescent from new infections is currently recommended for all clinical antimalarial efficacy trials by the World Health Organization. However, genotyping-adjusted drug efficacy estimates may vary between trials due to the use of different genotypi...
Autores principales: | Collins, William J, Greenhouse, Bryan, Rosenthal, Philip J, Dorsey, Grant |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716173/ https://www.ncbi.nlm.nih.gov/pubmed/17169157 http://dx.doi.org/10.1186/1475-2875-5-122 |
Ejemplares similares
-
Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in Uganda
por: Gupta, Vinay, et al.
Publicado: (2010) -
Incidence of Malaria and Efficacy of Combination Antimalarial Therapies over 4 Years in an Urban Cohort of Ugandan Children
por: Clark, Tamara D., et al.
Publicado: (2010) -
Associations between Antibodies to a Panel of Plasmodium falciparum Specific Antigens and Response to Sub-Optimal Antimalarial Therapy in Kampala, Uganda
por: Keh, Chris E., et al.
Publicado: (2012) -
Impact of a Rapid Decline in Malaria Transmission on Antimalarial IgG Subclasses and Avidity
por: Ssewanyana, Isaac, et al.
Publicado: (2021) -
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
por: Staedke, Sarah G, et al.
Publicado: (2008)